Better Nuclear Energy Stock: NuScale Power vs. Oklo

The article argues that small modular reactors could reach commercialization faster than traditional nuclear plants, highlighting NuScale and Oklo as potential beneficiaries of rising demand from data centers. Oklo appears to have the stronger near-term commercialization path, with management targeting initial commercial operations between late 2027 and early 2028 versus NuScale's 2030 timeline, though both remain speculative and pre-commercial. Oklo also cited more than $105 million in net losses in 2025, while NuScale's net loss exceeded $664 million, underscoring ongoing cash burn and execution risk.

Analysis

The market is starting to price SMRs less as a science project and more as an infrastructure-enablement layer for power-hungry workloads. That shifts the economic value chain away from pure reactor IP toward the harder bottlenecks: fuel fabrication, enrichment, permitting, EPC execution, and grid interconnection. In that framing, the early winners may not be the reactor designers alone, but the suppliers and partners that control scarce inputs and execution capability—especially companies that can monetize before first commercial electrons.

Oklo’s commercial edge is less about technology superiority than balance-sheet optionality: prepayment-like structures and strategic partners can de-risk capex and reduce dilution if management can translate LOIs into bankable offtake. The second-order effect is that the company becomes a financing arbitrage on data-center power demand; if hyperscalers continue to lock in capacity 3-5 years ahead, the market may reward signed contracted revenue more than NRC milestones. NuScale’s design certification is valuable, but in a capital-constrained buildout cycle, certification without visible project financing can remain a dead asset longer than the market expects.

The contrarian risk is that enthusiasm for SMRs may be front-running a regulatory and supply-chain bottleneck that has not yet been solved at scale. Nuclear fuel, specialized components, and qualified labor are all potential gating items; a delay in any one of them can push timelines by years and compress multiples sharply. This is also where the winner could flip: if timelines slip, the market may rotate from reactor equities into uranium/enrichment beneficiaries and adjacent power-infrastructure names with nearer cash-flow visibility.

Near term, the setup is likely a catalyst-driven trading stock rather than a fundamentals story, with volatility tied to partner announcements, financing updates, and permit progress over the next 6-18 months. A meaningful rerating likely requires one of two proof points: a fully funded project with a credible construction start, or a customer contract that survives beyond headline-stage announcement risk. Until then, the risk/reward is asymmetric only for the closer-to-revenue name, while the design leader remains exposed to repeated timeline resets.

Key Decisions for Investors

• Maintain a tactical long OKLO / short SMR pair trade for 3-9 months: thesis is that market will pay up for monetization path over certification pedigree; stop if NuScale announces fully financed build or material schedule pull-forward.
• Buy LEU as a second-order beneficiary over 6-12 months: if SMR deployment gains credibility, fuel-cycle capacity becomes a pricing choke point; upside comes from supply scarcity rather than single-project execution.
• Use call spreads on OKLO into catalyst windows (partner update, financing, permit milestones) rather than outright stock: captures upside from announcement-driven re-rates while limiting drawdown if timelines slip.
• Avoid chasing SMR on enthusiasm alone; wait for evidence of project financing or customer prepayments. The implied duration of cash burn is still the key risk, and any delay can force dilutive capital raises.
• If you want direct exposure to AI-driven power demand with less binary nuclear risk, prefer infrastructure/utility enablers over reactor equities; the market may reward contracted power delivery sooner than reactor commercialization.